nomifensine has been researched along with Liver Diseases in 2 studies
Nomifensine: An isoquinoline derivative that prevents dopamine reuptake into synaptosomes. The maleate was formerly used in the treatment of depression. It was withdrawn worldwide in 1986 due to the risk of acute hemolytic anemia with intravascular hemolysis resulting from its use. In some cases, renal failure also developed. (From Martindale, The Extra Pharmacopoeia, 30th ed, p266)
nomifensine : An N-methylated tetrahydroisoquinoline carrying phenyl and amino substituents at positions C-4 and C-8, respectively.
Liver Diseases: Pathological processes of the LIVER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The granulomas were located both in the portal tract and the liver parenchyma, and contained eosinophils and a few polynuclear giant cells." | 5.27 | [Granulomatous hepatitis caused by nomifensine]. ( Kummer, H; Marti, F; Wegmann, W, 1985) |
| "The granulomas were located both in the portal tract and the liver parenchyma, and contained eosinophils and a few polynuclear giant cells." | 1.27 | [Granulomatous hepatitis caused by nomifensine]. ( Kummer, H; Marti, F; Wegmann, W, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Weiss, M | 1 |
| Kummer, H | 1 |
| Marti, F | 1 |
| Wegmann, W | 1 |
2 other studies available for nomifensine and Liver Diseases
| Article | Year |
|---|---|
Use of metabolite AUC data in bioavailability studies to discriminate between absorption and first-pass extraction.
Topics: Absorption; Antipyrine; Biological Availability; Caffeine; Diphenhydramine; Dose-Response Relationsh | 1990 |
[Granulomatous hepatitis caused by nomifensine].
Topics: Aged; Biopsy; Chemical and Drug Induced Liver Injury; Female; Granuloma; Humans; Liver; Liver Diseas | 1985 |